Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Changes in Stockholders' Equity

v3.26.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance at Dec. 31, 2023 $ 1,699 $ 64,472,249 $ (63,980,177) $ (16,260) $ 477,511
Balance, shares at Dec. 31, 2023 16,986,254        
Issuance of restricted stock $ 7 179,483 179,490
Issuance of restricted stock, shares   75,550        
Exercise of stock options $ 12 217,146 217,158
Exercise of stock options, shares   120,110        
Stock-based compensation expense 1,912,744 1,912,744
Issuance of common shares in connection with At-The-Market financing, net of $658,801 of issuance costs $ 328 9,452,867 9,453,195
Issuance of common shares in connection with At-The-Market financing, net of issuance costs, shares   3,274,360        
Exercise of warrants $ 54 3,191,621 3,191,675
Exercise of warrants, shares   545,309        
Foreign currency translation adjustment (14,355) (14,355)
Net loss (23,254,656) (23,254,656)
Issuance of common shares in connection with the Private Placement Offerings, net of $136,456 of issuance costs $ 516 2,683,987 2,684,503
Issuance of common shares in connection with the Private Placement Offering, net of issuance costs, shares   5,156,205        
Issuance of warrants in connection with the Private Placement Offerings 1,917,075 1,917,075
Reclassification of liability classified warrants to equity 6,870,296 6,870,296
Balance at Dec. 31, 2024 $ 2,616 90,897,468 (87,234,833) (30,615) 3,634,636
Balance, shares at Dec. 31, 2024 26,157,788        
Issuance of restricted stock $ 50 618,763 618,813
Issuance of restricted stock, shares   506,823        
Exercise of stock options 844 $ 844
Exercise of stock options, shares   570       570
Stock-based compensation expense 2,631,652 $ 2,631,652
Issuance of common shares in connection with At-The-Market financing, net of $658,801 of issuance costs $ 379 6,874,022 6,874,401
Issuance of common shares in connection with At-The-Market financing, net of issuance costs, shares   3,782,335        
Issuance of common shares in connection with the Private Placement Offerings, net of $289,518 of issuance costs $ 752 6,023,757 6,024,509
Issuance of common shares in connection with the Private Placement Offerings, net of issuance costs, shares   7,516,987        
Issuance of warrants in connection with the Private Placement Offerings 4,105,215 4,105,215
Exercise of warrants $ 66 901,512 901,578
Exercise of warrants, shares   659,786        
Foreign currency translation adjustment (19,613) (19,613)
Net loss (22,396,172) (22,396,172)
Balance at Dec. 31, 2025 $ 3,863 $ 112,053,233 $ (109,631,005) $ (50,228) $ 2,375,863
Balance, shares at Dec. 31, 2025 38,624,289